













































Aging is an important risk factor for chronic diseases 
such as type 2 diabetes (T2D) [1]. Dietary restriction 
(DR) increases lifespan and delays the onset of T2D in 
mammals, including humans [2, 3]. This is thought to 
be a consequence of increased insulin sensitivity and 
improved  glucose  disposal,  although  the  mechanisms  
 
 













































underlying these effects of DR have not yet been 
elucidated in detail. Among the proposed mechanisms, 
DR has been shown to ameliorate oxidative imbalance 
[4] and inflammation [5, 6] in a variety of tissues, 
including the white adipose tissue (WAT), contributing 
therefore to enhance local and whole body insulin 
signaling [7-9].  
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WAT plays a major role in glycemic control and in 
nutrient homeostasis, serving as the main site for calorie 
storage during the fed state and as the source of 
circulating free fatty acids during the fasting state [10]. 
WAT is also a major endocrine organ [11] and the 
primary site of branched-chain amino acid (BCAA, e.g. 
valine, leucine, and isoleucine) oxidation [12]. Indeed, 
impaired BCAA metabolism in adipose tissue and 
BCAA accumulation in the blood stream have been 
associated with T2D [13].  
 
Dicer is a type III endoribonuclease that processes pre-
miRNAs into mature miRNAs and exerts a variety of 
other functions related to double-stranded RNA 
processing and degradation [14]. We have previously 
reported that DR prevents the age-associated 
downregulation of Dicer in murine WAT, reversing a 
global decline in miRNAs that occurs with aging [15].  
Dicer expression in adipose tissue is also downregulated 
in response to obesity and lipodystrophy in mice and 
humans [16-18], and is affected by aging and DR in C. 
elegans in a manner that resembles the phenomenon 
observed in mouse adipose tissue [15]. Worms 
overexpressing Dicer in the intestine - the analog of 
mammalian adipose tissue - are stress resistant, while 
whole body Dicer loss-of-function mutations render 
worms short-lived [15]. Fat-specific Dicer knockout 
(AdicerKO) mice are insulin resistant and 
hyperglycemic when subjected to high fat diet [16], 
suggesting that downregulation of Dicer in adipose 
tissue contributes to aging and age-associated T2D. 
Here we tested this hypothesis and asked if DR provides 
beneficial metabolic outcomes through the upregulation 
of Dicer in WAT. We found that Dicer is required for 
proper nutrient utilization by the adipose tissue 
particularly in catabolic states. Moreover, Dicer loss-of-
function in adipocytes directly impacts on the 
accumulation of circulating metabolites that play a role 
in controlling whole body insulin action. Consequently, 
DR is unable to improve insulin sensitivity in AdicerKO 
mice. Finally, these mice exhibit age-dependent insulin 
resistance and premature mortality, suggesting a critical 





Altered serum metabolite profiles in AdicerKO mice 
 
Twelve-week old AdicerKO and Lox mice were 
maintained on DR or ad libitum (AL) regimens and 
euthanized when fasting at the end of the protocol. As 
expected, mice on DR lost weight and visceral 
adiposity, and this was independent of the genotype 
(Supplementary Fig. 1A and B). AdicerKO mice had 
larger brown adipose tissue mass and smaller 
epididymal mal WAT depots when fed AL, as 
previously described [16], and these differences 
persisted under the DR condition (Supplementary Fig. 
1B). Surprisingly, DR promoted more subcutaneous 
inguinal WAT (henceforth referred to simply as WAT) 
loss in AdicerKO than in the Lox mice (Supplementary 
Fig. 1B).  
 
To test if the absence of Dicer in adipocytes could lead 
to systemic metabolic changes in AL or DR mice, we 
performed serum metabolomics. Partial least squares 
discriminant analysis (PLS-DA) (Supplementary Fig. 
2A) and hierarchical clustering analysis (Supplementary 
Fig. 2B) revealed a distinct pattern between the groups, 
in particular between DR and AL, but also between 
AdicerKO and Lox mice. Pathway analysis 
demonstrated that metabolites related to fatty acid 
oxidation, BCAA degradation and biosynthesis, 
pantothenate and CoA biosynthesis, aromatic amino 
acid biosynthesis, and glycerophospholipid metabolism 
were the most overrepresented among the differentially 
expressed serum constituents when comparing all 
conditions (Supplementary Table 1). Dicer knockout in 
adipocytes did not completely abrogate the effects of 
DR on the levels of specific serum metabolites; 
however it did increase the circulating levels of BCAA 
and other essential amino acids both under AL 
(Supplementary Table 2) and DR conditions (Fig. 1A 
and B). Short-chain acylcarnitines (SCAC) 
(Supplementary Fig. 2C and D) and glycerol-
phospholipids (Supplementary Fig. 2B) were also 
higher in the serum of AdicerKO mice under these 
conditions. 
 
Metabolic rewiring in the adipose tissue of 
AdicerKO mice 
 
The changes in circulating BCAA and SCAC levels in 
AdicerKO mice prompted us to investigate potential 
differences in the expression of genes related to amino 
acid and fatty acid metabolism in WAT - a major site for 
BCAA and fatty acid oxidation [12, 19]. Genes encoding 
branched-chain aminotransferases (Bcat1 - cytoplasmic 
and Bcat2 -mitochondrial) – the first step in the BCAA 
degradation pathway - were lower by 52 to 89% in 
AdicerKO WAT, especially the mitochondrial isoform 
Bcat2, which was also induced by DR in both genotypes 
(Fig. 1C). Branched-chain alpha-ketoacid dehydrogenase 
mRNA (Bckdha) was not changed (Fig. 1C). We also 
measured the mRNA expression of enzymes involved in 
the catabolism of other amino acids, e.g. L-amino acid 
oxidase 1 (Lao1), tyrosine aminotransferase (Tat), and 
glutamic-oxaloacetic transaminases (Got1 – cytoplasmic 
and Got2 – mitochondrial) (Fig. 1D). We observed no 
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changes except for Got1, which was dramatically 
increased by 7.5- and 86.3-fold with DR in Lox and 
AdicerKO mice, respectively. Acetyl-CoA carboxylase 
beta mRNA (Acacb) expression was markedly reduced in 
the WAT of AdicerKO mice under both AL and DR 
conditions, despite minor or no consistent changes in 
mRNA expression of carnitine palmitoyltransferase Ia 
(Cpt1a) and Ib (Cpt1β) or short chain fatty acid acyl-
coenzyme A dehydrogenase (Acads) (Fig. 1E). The 
mRNA encoding for long chain fatty acid acyl-coenzyme 
A dehydrogenase (Acadl) was lower in the WAT of 
AdicerKO mice only during DR (Fig. 1E). Taken 
together with elevated serum SCAC levels in AdicerKO 
mice (Supplementary Fig. 2C and D) with no changes in 
palmitoylcarnitine (Supplementary Fig. 2E) or carnitine 
(Supplementary Fig. 2F), these results suggest reduced 
BCAA catabolism and altered fatty acid oxidation. In 
agreement with this hypothesis, two of the major 
transcription factors involved in the regulation of genes 
of the mitochondrial β-oxidation, i.e. PGC-1α and PPAR-
α, had their mRNAs dramatically decreased in WAT of 
AdicerKO mice in both AL and DR regimens (Ppargc1a 

































Surprisingly, isolated WAT or skeletal muscle of 
AdicerKO mice were able to efficiently oxidize valine 
(Supplementary Fig. 3A-H) or palmitate (Supplemen-
tary Fig. 3I-L) into CO2, or direct their carbons to ward 
lipid synthesis (Supplementary Fig. 3M-R), 
independently of the diet, when these substrates were 
offered in excess as an exogenous energy source. These 
data suggest that oxidative capacity of AdicerKO WAT 
and muscle is not compromised. Indeed, the capacity to 
reduce cytochrome c was preserved in the WAT of 
AdicerKO mice when NADH was offered as a substrate 
to promote electron transport starting at complex I (Fig. 
2A). However, electron transport was less efficient in 
AdicerKO WAT when succinate was used to feed 
complex II directly (Fig. 2B). These results indicate that 
electron transport function is impaired at the level of 
complex II in AdicerKO WAT. Consistently, AdicerKO 
adipocytes displayed lower respiratory rates in the 
presence of  succinate (Fig. 2C), indicating that fat cells 
in which Dicer was knocked out engage less in 
oxidative metabolism. 
































Figure 1. Metabolic  changes  in  fat‐specific Dicer  knockout mice  (AdicerKO).  Twelve‐week  old mice were  subjected  to  ad
libitum  (AL) or dietary  restriction  (DR)  regimens  for  three months. Mice were euthanized at  the end of  the protocol after overnight






































Decreased respiration in the WAT of AdicerKO mice 
could be caused by low substrate availability. The levels 
of NADH – the major substrate for the electron 
transport chain (ETC) – did not differ in WAT of Lox 
vs. AdicerKO mice, but trended upwards more 
dramatically in Lox compared to AdicerKO mice with 
DR, although these differences did not reach statistical 
significance (Fig. 2D). NAD+ levels were similarly 
increased with DR independently of the genotype (Fig. 
2E) and no differences were observed in the 
NAD+/NADH ratios (Fig. 2F). ATP levels were similar 
between the groups (Fig. 3A), while lactate levels were 
3.3-fold higher in AdicerKO mice subjected to DR 
when compared to the Lox controls on the same 
regimen (Fig. 3B), indicating a counterintuitive shift 
towards anaerobic metabolism in AdicerKO mice 
during a state of negative energy balance.  
     
Reduced mitochondrial biogenesis in AdicerKO 
WAT under DR 
 
We next hypothesized that reduced oxidative 

































drial mass and/or number in the WAT of AdicerKO 
mice. Mitochondrial DNA (mtDNA), a marker of 
mitochondrial mass, was reduced in the WAT of 
AdicerKO mice fed AL when compared to the Lox 
controls, and increased by a similar level in both 
genotypes upon DR (Fig. 3C). Citrate synthase level - a 
second mitochondrial mass marker - was not different 
when comparing Lox and AdicerKO mice under the AL 
regimen; however it increased significantly in response 
to DR in Lox but not in AdicerKO WAT (Fig. 3D). 
Similar patterns were observed when we measured the 
expression of nuclear- and mitochondria-encoded genes 
of the ETC (Fig. 3E), as well as the mitochondrial 
transcription factor Tfam (Fig. 3F).  
 
Consistent with a causal role of Dicer in promoting 
WAT mitochondrial biogenesis in response to DR, and 
reinforcing the importance of this protein in the early 
events of the dietary intervention, both Dicer protein 
levels and the mitochondrial complex I marker Ndufs8 
were upregulated by as early as 3.5-days of DR 
(Supplementary Fig. 4 A-C). Dicer expression was 
further increased with time and reached maximum 
Figure 2. Respiration  in white adipose  tissue of AdicerKO mice.  Twelve‐week  old mice were  subjected  to  ad  libitum  (AL)  or
dietary  restriction  (DR)  regimens  for  one month.  Inguinal white  adipose  tissue  (WAT) was  isolated  and  cytochrome  c  reduction was
measured when NADH  (A) or  succinate  (B) was used as  substrate  to assess ETC  complex  I‐III or  II‐III activity,  respectively  (N=3‐5 per
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upregulation within 10.5-days of DR (Supplementary 
Fig. 4B). In addition, to test if it was the ablation of 
Dicer in adipocytes or the consequent age-dependent 
lipodystrophic phenotype of AdicerKO mice that 
blocked the effect of DR over mitochondrial biogenesis 
in WAT, we studied the effect of the regimen in young 
mice, before the onset of lipodystrophy [16]. Consistent 
with a direct role of Dicer in mitochondrial biogenesis, 
DR induced the expression of ETC genes in WAT of 8-
week old Lox mice, but not in aged matched AdicerKO 
mice (Supplementary Fig. 4D). These data demonstrate 
that DR promotes a robust induction of mitochondrial 
biogenesis in WAT that is blocked by adipocyte-
specific Dicer loss-of-function.  
 
In agreement with the molecular data, electron 
microscopies of the WAT revealed less abundant 
mitochondria in the WAT of AL-fed AdicerKO mice 
(Fig. 4A). On the other hand, while DR induced 
accumulation of healthy-looking mitochondria in the 


































dria with highly irregular shapes and aberrant cristae in 
AdicerKO mice, hallmarks of a dysfunctional organelle 
(Fig. 4A and B).  
 
Structural changes in the WAT of AdicerKO mice 
upon DR  
 
To assess if the differences in substrate utilization and 
mitochondrial mass were associated with morphological 
changes in the WAT of AdicerKO mice, we performed 
histological analyses. Adipocytes of AdicerKO mice 
tended to be larger and more unilocular than those of 
Lox mice on the AL diet (Fig. 4C and Supplementary 
5A and B), but these differences did not reach statistical 
significance. Under DR, adipocytes of Lox became 
multilocular, while the tissue of AdicerKO appeared 
fibrotic and filled with cell infiltrate in some areas (Fig. 
4C). Consistently, markers of inflammation were 
increased in the WAT of AdicerKO mice upon DR, in 
contrast with the effect of DR on Lox mice, which 


















































































Surprisingly, protein carbonylation (Supplementary Fig. 
5C) and glutathione levels (Supplementary Fig. 5D) - 
markers of oxidative damage - were not changed or 
minimally affected among the groups. 
 
Insulin resistance in AdicerKO mice 
 
Mitochondrial dysfunction in the adipose tissue and 
increased inflammation are often associated with insulin 
resistance [20, 21]. Indeed, AdicerKO mice are insulin 
resistant, in particular at the level of the adipose tissue 
[[16] and Fig. 5]. Strikingly, AdicerKO mice remained 
insulin resistant even under the DR regimen (Fig. 5A), 
despite showing improved glucose tolerance 
(Supplementary Fig. 6A) when compared to mice on the 








































KO mice was associated with reduced insulin signaling 
in WAT as measured by Akt and Erk1/2 
phosphorylation (Fig. 5B). Interestingly, deletion of 
Dicer in adipocytes led to downregulation of total Akt 
levels and selective inhibition of insulin-induced p42 
(Erk2) phosphorylation (Fig. 5B). Akt is phosphorylated 
at Ser473 by the insulin-dependent, rapamycin-
insensitive mTORC2 complex [22]. On the other hand, 
mTORC2 is inhibited by chronic stimulation of the 
mTORC1 complex, which is in turn activated by BCAA 
[23]. We thus estimated basal mTORC1 activity by 
assessing the phosphorylation of the ribosomal protein 
S6. S6 phosphorylation was markedly increased in 
WAT of AdicerKO mice, both under the AL and DR 
regimens (Fig. 5C), indicating hyperactivation of 
mTORC1. Since we found increased levels of 







www.impactaging.com                      6                                            AGING, May 2016, Vol. 8 No.5
circulating BCAA in AdicerKO mice, we asked whether 
other non-adipose tissues also showed elevated mTORC1 
activity. Indeed, S6 phosphorylation was increased in 
skeletal muscle of AdicerKO mice under both regimens, 
despite no changes in Akt or Erk phosphorylation (Fig. 
5D). On the other hand, phosphorylation of Erk was 
reduced in liver of AdicerKO mice with no changes in 
Akt (Supplementary Fig. 6B). 
 
If hyperactivation of mTORC1 in insulin-sensitive 












































mice, one would expect this phenotype to be reversed 
by selective inhibition of mTORC1, as previously 
shown [24]. In agreement with this notion, acute 
rapamycin injection not only markedly improved insulin 
sensitivity in AdicerKO mice on the AL diet, but also 
completely reversed insulin resistance of these mice 
under the DR regimen (Fig. 5E and F). These results 
demonstrate that increased mTORC1 activation - 
possibly due to elevated levels of circulating BCAA - 

















































AdicerKO DR.  (B‐D) Western blots of  tissue extracts when  (B)  insulin was  injected  in  the  inferior vena cava and WAT was collected 5
minutes after, or  (C,D) at basal,  random  fed state. WAT,  inguinal white adipose  tissue. Muscle, gastrocnemius. +,  the presence of  the















































AdicerKO mice exhibit age-associated insulin 
resistance and increased premature mortality risk 
 
Next, to test whether insulin resistance in AdicerKO 
mice was associated with aging, we performed insulin 
tolerance tests in young (4 month-old) and old (18-
month-old) mice that had AL access to chow during 
their entire lifespan. Insulin resistance was minimal in 
young AdicerKO mice, while in old animals it was 
markedly different (Fig. 6A). We also determined the 
life expectancy of these mice. Median survival was not 
different between Lox and AdicerKO mice [Males: Lox 











































6B); Females: Lox vs. AdicerKO = 25.5 vs. 23.7 
months, P = 0.5579 (Fig. 6C)], but Gompertz modeling 
[25] revealed that the initial mortality rate 
(vulnerability) was significantly higher in AdicerKO 
mice with no difference in age-dependent mortality 
(aging rate). Furthermore, female AdicerKO mice 
exhibited more frequent signs of senescence (such as 
hair loss or graying) at their median lifespan (24 months 
of age) than did Lox mice (Fig. 6D). Hence, AdicerKO 
mice are more prone to early death and trend toward 
premature aging, but the animals that survive to the last 
quartile of their lifespan seem to be as sensitive to age-









































The regulation of Dicer expression in the adipose tissue 
and its consequent impact on global miRNA levels have 
been proposed to represent an evolutionarily conserved 
feature of aging and a mechanism through which DR 
delays the aging process [15, 18]. Here we used mice 
lacking Dicer in adipocytes (AdicerKO) to directly test 
these hypotheses. Metabolomic analyses reveal marked 
changes in the levels of BCAA and SCAC in the blood 
stream of fasted, middle-aged AdicerKO in comparison 
to Lox mice, both under the DR and AL regimens. 
These changes are in agreement with the low oxidative 
profile of AdicerKO adipocytes. Under short-term DR, 
the adipose tissue of Lox mice activates a program of 
mitochondrial biogenesis and oxidative metabolism, 
whereas the fat tissue of AdicerKO mice shifts its 
metabolism towards anaerobic glycolysis while 
abrogating mitochondrial biogenesis. In turn, this leads 
to tissue dysfunction and inflammation, which 



































Insulin resistance in AdicerKO mice is partially or 
entirely explained by hyperactivation of mTORC1, 
depending on the dietary regimen. mTORC1 is 
activated by BCAA [23], which are elevated in the 
serum of AdicerKO mice. When activated, mTORC1 
leads to phosphorylation of S6 kinase, which in turn 
phosphorylates IRS1 in a serine residue, therefore 
inhibiting it and impairing insulin signaling [27, 28]. S6 
kinase knockout mice are long-lived and display 
characteristics that resemble the effects of DR, such as 
protection from age-dependent insulin resistance [29]. 
Conversely, high levels of circulating BCAA in obesity 
and chronic mTORC1 activation have been previously 
linked to T2D and aging in humans and animal models 
[13, 30-34]. Another facet of BCAA-induced insulin 
resistance is related to increased BCAA catabolism in 
the muscle, which leads to incomplete fatty acid 
oxidation, gives rise to SCAC that allosterically inhibit 
citrate synthase, results in mitochondrial stress and 
impairs insulin action [13]. Hyperactivation of 
mTORC1 also shifts metabolism towards glycolysis and 





www.impactaging.com                      9                                            AGING, May 2016, Vol. 8 No.5
de novo lipid biosynthesis [35], which in sum are 
phenotypes observed in the AdicerKO mouse under DR. 
Adipose tissue is a major site for BCAA oxidation and 
this process is impaired during T2D [12, 13, 19, 30]. 
Dicer expression is decreased in the adipose tissue of 
mouse models and humans with increased risk for T2D, 
such as during obesity, aging and lipodystrophy [15, 16, 
18], while increased upon DR [15]. Based on this 
scenario, we conclude that higher levels of Dicer in 
adipose tissue are necessary to sustain a proper response 
to fluctuations in energy demands by conferring 
adequate substrate utilization and promoting oxidative 
metabolism. When nutrients are particularly limiting, 
reduced levels of Dicer negatively impact on adipose 
tissue oxidative metabolism, raising the blood levels of 
BCAA and SCAC, contributing to mTORC1 activation 
and resulting in whole body insulin resistance (Fig. 7). 
Consistent with this notion, AdicerKO mice do not 
benefit from some of the classic metabolic outcomes of 
DR, such as increased insulin sensitivity and decreased 
inflammation, and have accelerated age-dependent 
insulin resistance and premature mortality.    
  
Dicer knockout in adipocytes leads to partial 
lipodystrophy in middle-aged mice as manifested by 
decreased intra-abdominal fat accumulation and 
hypertrophy and “whitening” of the interscapular brown 
fat depot [16]. Since the subcutaneous inguinal fat pad 
is not grossly affected in size or morphology in chow 
diet fed, young adult AdicerKO mice [[16] and this 
study], and given that the impact of aging and DR on 
Dicer expression is more clearly manifested in this 
tissue [15], we decided to focus our efforts on this 
depot. By doing so we wanted to minimize 
developmental changes in adipose tissue composition 
and essentially look for changes that occurred in 
response to DR or aging. Indeed, some of the 
observations made in 3-month old AdicerKO mice 
subjected to DR were confirmed in younger mice, prior 
to the onset of lipodystrophy. These experiments 
corroborate the notion that Dicer expression in 
adipocytes is required for a proper response to DR, and 
not that lipodystrophy mitigates the effect of the diet. In 
agreement, short term (3.5 days), moderate (10%) DR is 
able to upregulate Dicer in adipose tissue of wild type 
mice while also upregulating genes of the mitochondrial 
ETC, prior to changes in body weight. 
 
The differences in the expression of mitochondrial and 
β-oxidation-related genes in the adipose tissue of 
AdicerKO versus Lox mice are particularly evident 
under DR. Likewise, lactate levels are increased in the 
fat tissue of AdicerKO mice only in response to this 
dietary regimen, pointing towards a shift to anaerobic 
glycolysis during a state of chronic catabolism. 
Intriguingly, there is a concomitant increase in 
triglyceride synthesis from valine in the adipose tissue 
of AdicerKO mice on DR, which suggests diversion of 
carbons to lipid anabolism. Increases in anaerobic 
glycolysis and in the flux through anabolic pathways 
under nutrient limiting states also occur in many cancer 
cells and are often referred to as the Warburg effect 
[36]. Interestingly, as in Dicer knockout adipocytes, 
many of these cancer cells have decreased Dicer levels 
[37] and reduced oxidative activity [36]. Thus, our data 
suggest that Dicer knockout adipocytes exhibit a 
Warburg-like behavior when put on nutrient restriction, 
somewhat resembling the behavior of cancer cells. This 
could be linked to the activation of senescence and 
inflammation pathways that are hallmarks in the 
adipose tissue of AdicerKO mice and in Dicer knockout 
preadipocytes (this study and [15]).  
 
The question that remains is why Dicer knockout 
adipocytes actively divert to non-oxidative metabolism 
when subjected to nutrient restriction despite having 
adequate mitochondrial capacity and plenty of 
substrates. One possible explanation is that under DR, 
Dicer upregulation in wild type adipocytes leads to the 
increase of miRNAs that suppress glycolytic genes to 
favor oxidative metabolism, a phenomenon that would 
not occur in AdicerKO mice. Dicer levels may be rate-
limiting for these miRNAs or their effects may become 
more evident in a situation when catabolic flux is 
promoted. Indeed, when lactate or mitochondrial gene 
expression is assessed in various cell culture models of 
Dicer knockout preadipocytes, no differences are 
observed when comparing these cells to the wild type 
(unpublished data). These cells are cultured and 
differentiated into adipocytes in an atmosphere of 20% 
oxygen and in high glucose, high growth factor 
medium, which is distant from the pseudo-hypoxic, 
highly oxidative and growth limiting conditions of DR 
in vivo. Moreover, the cells are not exposed to the 
changes in circulating factors that occur during DR or in 
response to fat-specific Dicer knockout. Hence, more 
studies are required to determine the exact mechanism 
through which Dicer controls adipocyte metabolism 
during catabolic states. 
 
We and others have shown that Dicer is pivotal in stress 
responses, metabolic diseases and aging [15, 38, 39]. 
miRNAs are involved in specific aspects of these 
mechanisms [39-43], but they are differently expressed, 
play different roles in distinct cell types and conditions 
and are unlikely to individually explain the plethora of 
phenotypes that are characteristic of aging or T2D [44]. 
Furthermore, while miRNAs are likely to participate as 
downstream molecular players involved in the 
phenotypes of AdicerKO mice, Dicer also binds to and 
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directly controls the levels of a wide range of RNAs in 
the cell, including other non-coding RNAs such as 
tRNAs or even mitochondrial-encoded mRNAs [14]. 
Therefore, we propose a scenario where during 
metabolic stress, Dicer becomes rate-limiting for the 
biosynthesis of certain RNAs while promoting the 
degradation of others. These downstream RNAs may 
vary depending on the cell type, condition or degree of 
cell differentiation. Dicer upregulation will then favor 
these processes to promote context-specific adaptation 
to stress and increase cell robustness [45]. When this 
occurs in adipocytes, context-specific adaptation to 
metabolic stress leads to proper substrate utilization and 
results in efficient nutrient mobilization to metabolic 
tissues that depend largely on the adipose tissue in 
situations of calorie deprivation, such as the skeletal 
muscle. This confers more efficient usage of the 
scarcely available energy and also contributes to 
organismal metabolic plasticity, which in turn protects 
from premature metabolic diseases and eventually 
death. It also prevents the accumulation of circulating 
metabolites (such as BCAA) that act as signaling 
molecules to activate pathways that are positively 
involved in growth and energy storage while negatively 
involved in longevity (such as the mTOR pathway) 
(Fig. 7).  
 
In conclusion, we now provide direct evidence that 
adipose tissue Dicer is necessary for proper nutrient 
utilization by adipocytes and essential for the beneficial 
effects of DR, such as improved whole-body insulin 
sensitivity. We also demonstrate that adipocyte-specific 
Dicer knockout is sufficient to accelerate the appearance 
of insulin resistance in mice, while leading to premature 
mortality. Our study and the evolutionary conserved 
association between Dicer regulation, metabolic 
diseases and aging set the stage for new interventions to 
prolong healthspan in humans.  
 
MATERIALS AND METHODS 
 
Animals. Fat-specific Dicer knockout mice (AdicerKO) 
and their littermate controls (Lox) were obtained from 
the Centro de Desenvolvimento de Modelos 
Experimentais para Medicina e Biologia (CEDEME) of 
the Universidade Federal de São Paulo. Males were 
used in all cases unless stated otherwise. Mice were 
maintained on a 12-hr light-dark cycle with ad libitum 
access to tap water and chow diet. Dietary restriction 
was performed according to the protocol of the National 
Institute on Aging [15, 46]. Food intake and body 
weight was assessed weekly. Mice were euthanized at 
the indicated time-points during random feeding unless 
indicated otherwise. After euthanasia, tissues were 
collected, weighed and immediately used or frozen in 
dry ice and stored at -80oC. Protocols for animal use 
were approved by the IACUC of the Universidade 
Federal de São Paulo (CEP-0218/11, CEP-0237/12 and 
CEUA4603261015) and were in accordance with NIH 
guidelines. 
 
Metabolomics. Serum metabolites were measured by 
mass spectrometry (BIOCRATES Life Sciences). The 
results were analyzed using MetaboAnalyst 
(www.metaboanalyst.ca) [47]. Values were normalized 
by the pooled average value from the Lox AL group, 
Log2 transformed, and Pareto scaled (mean-centered 
and divided by the square root of standard deviation of 
each variable).  
 
Western blotting and qPCR. These methods were 
performed as described previously [15, 16]. For 
mitochondrial DNA quantitation, total DNA was 
extracted using DNeasy Blood & Tissue kit (Qiagen) 
and subjected to qPCR using primers targeting 
mitochondrial or nuclear DNA. Antibodies were: Dicer 
(Ab13502) from Abcam and phosphor-S6 (5364), Akt 
(9272), phosphor-Akt (9271), Erk (9102), phospho-Erk 
(9101), and β-tubulin (2146) from Cell Signaling. The 
primer sequences will be made available upon request. 
 
Mitochondrial enzymatic activity. Inguinal white 
adipose tissue was disrupted in 0.1 M potassium 
phosphate buffer with 5 mM EDTA using a Dounce 
homogenizer. The homogenate was centrifuged at 
10,000 x g for 10 min at 4 ˚C to remove the fat, and the 
supernatant was used for protein quantification (BCA 
kit, Pierce) and determination of citrate synthase and 
electron transport activities. Citrate synthase was 
determined as previously described [48] using 3-10 µg 
of total homogenate. Activity of complexes II-III or I-
III was assayed as described in [49], using 80-150 µg of 
total homogenate and succinate or NADH as substrates, 
respectively. The rate of cytochrome c reduction that 
was insensitive to antimycin A was subtracted from all 
measurements. 
 
Substrate oxidation. Valine oxidation into CO2 or α-
ketoisovaleric acid (αKIV) was measured according to 
[12] with slight modifications. Palmitate oxidation and 
incorporation into lipids was measured as described 
previously [50]. Briefly, tissues were minced, weighed 
and placed into glass tubes (approximately 10 mg per 
tube) containing 0.5 ml of Krebs-Ringer bicarbonate 
buffer [in mM: 118 NaCl, 4.8 KCl, 1.25 CaCl2, 1.2 
KH2PO4, 1.2 MgSO4, 25 NaHCO3, 10 HEPES (pH 
7.4)]. For valine assays, the buffer was supplemented 
with 5 mM glucose and 1 mM valine containing 0.2 µCi 
[U-14C] valine per tube. For palmitate assays, the buffer 
was supplemented with 100 µM palmitate containing 
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0.2 µCi [U-14C] palmitate per tube. For adipose tissue 
samples, the buffer was also supplemented with 2% 
(w/v) BSA (fatty acid free). For muscle samples, the 
buffer was supplemented with 0.2% (w/v) BSA. A dry 
piece of Whatman paper was placed inside the tube 
around its upper part, with no direct contact with the 
buffer, in order to absorb the CO2 produced. The tubes 
were sealed with parafilm and tissue explants were 
incubated with shaking at 37 °C. After 1h, the reaction 
was terminated with the injection of 200 µL of 6N 
sulfuric acid into the reaction mixture and 200 µL of 
phenyletilamine:methanol (1:1) onto the Whatman 
paper. After 20 min the paper was collected. In the 
valine assays, the paper was replaced and the tubes were 
resealed. Hydrogen peroxide (200 µL, 30% w/v) was 
injected into the reaction mixture and 200 µL of 
phenyletilamine:methanol (1:1) onto the paper for 
collecting the CO2 generated by the decarboxylation of 
αKIV. Explants were removed and destined to lipid 
extraction with 1 mL of chloroform:methanol (2:1). 14C 
radioactivity was assessed in the papers or lipid extracts 
and normalized by tissue weight.  
 
Oxygen consumption. Oxygen consumption was 
performed in isolated adipocytes using the Oroboros 
O2k oxygraph. Adipocytes from the inguinal fat depots 
were isolated and respiratory rate was measured as 
previously described [51, 52]. Adipocytes from 3-5 
mice per group were pooled in KRP buffer (130 mM 
NaCl, 4.7 mM KCl, 1.24 mM MgSO4, 2.5 mM CaCl2, 
10 mM HEPES, 2.5 mM NaH2PO4, 5 mM D-glucose, 
2% BSA). Respiration was measured in KRP devoid of 
BSA. 1 mM succinate and 0.5 µg/ml antimycin A were 
added sequentially. Respiration before addition of 
succinate was subtracted from all rates. Succinate-
dependent respiration was obtained by subtracting 
antimycin A-insensitive respiratory rate. Values were 
normalized by the number of cells and expressed as 
percentage of Lox. 
 
Biochemical analyses. For lactate and ATP assays, 
tissues were homogenized in 4% trichloroacetic acid 
and subjected to two rounds of centrifugations for 5 min 
at 13,000 g and 4 ˚C. The supernatant had the pH 
adjusted to 7.0 and was used for lactate quantitation as 
described in [53] or ATP measurement using an ATP 
Bioluminescent Assay Kit from Sigma-Aldrich. NAD+ 
and NADH were measured using the NAD/NADH 
Assay Kit from Bioassays. Values were normalized by 
tissue weight. For glutathione determination, tissue 
homogenates (diluted in 0.1 M potassium phosphate 
buffer/5 mM EDTA) were de-proteinized by addition of 
0.6% sulfosalycilic acid/0.1% Triton X-100 and 
centrifugation for 10 min at 8,000 x g and 4 ˚C. The 
supernatant was used for glutathione determination as 
described in [54]. Glutathione levels were normalized 
by the protein content in the pre de-proteinized aliquot, 
as measured by the BCA kit (Pierce). 
 
Protein carbonylation. One volume of protein extract 
(maximum protein concentration of 4 mg/mL) was 
mixed with one volume of 24% SDS and one volume of 
40 mM 2,4-dinitrophenylhydrazine solution. The 
mixture was incubated for 30 min at room temperature 
in the dark. A neutralizing solution containing 2 M Tris, 
30% Glycerol and 19% mercaptoethanol was titrated 
into the mixture until it became orange. The neutralized 
mixture was then subjected to western blotting using 
equal amounts of protein and an antibody targeting 
dinitrophenyl (D9656) from Sigma-Aldrich. 
 
Microscopy. Microscopy analyses were performed as 
previously described [55]. Briefly, mice were 
anesthetized and transcardiacally perfused for 5-8 min 
with 2% glutaraldehyde in 0.1 M phosphate buffer (pH 
7.4). After perfusion, WAT was isolated and kept in 
0.1% glutaraldehyde/0.1 M phosphate buffer (pH 7.4). 
Thin sections were obtained with an MT-X ultratome 
(RMC). Slices were separated for histological analyses 
and stained with hematoxylin and eosin (H&E). For 
transmission electron microscopy, slices were stained 
with lead citrate and examined with a CM10 transmis-
sion electron microscope (Philips). Morphometric 
evaluation of adipocytes was performed blindly using 
image analysis software (Lucia IMAGE Software, 
Laboratory Imaging). H&E images were used for 
determination of mean adipocyte size and adipocyte 
type.  
 
Insulin sensitivity and glucose tolerance. Glucose and 
insulin tolerance tests were performed one week prior to 
the euthanasia and followed the protocols described 
elsewhere [16]. Briefly, mice were injected 
intraperitoneally with glucose (1 g/kg body weight) 
after overnight fasting or insulin (0.75U/kg body 
weight; Humalog, Eli Lilly) after 2h fasting. Blood 
samples were collected at the indicated time-points 
through a small cut at the tail tip of the mouse and 
glucose levels were measured using a glucometer 
(Accu-Chek, Roche). When indicated, rapamycin (LC 
laboratories) was given i.p. (5 mg/kg body weight in 
0.2% methylcellulose) 2h prior to the insulin injection.  
To assess insulin signaling, mice were fasted overnight, 
anesthetized and injected with a bolus of insulin (10 U) 
into the inferior vena cava. After 5 min, mice were 
euthanized and WAT was collected. Phosphorylation of 
Akt and Erk was determined by western blotting.   
 
Life expectancy. Kaplan-Meier curves were determined 
for ad libitum, chow diet fed male and female mice. 
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Median lifespan was assessed using GraphPrism and 
Gompertz modeling using JMP.  
 
Statistical analysis. Results are expressed as the mean ± 
standard error of the mean (SEM) unless indicated 
otherwise. We used Student t test to compare two 
independent groups and ANOVA to compare more than 
two groups. Two-way ANOVA was used when data had 
more than one categorical independent variable. We 
used the MetaboAnalyst package of statistical tools to 
analyze and test the metabolomic data. Statistical 
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Supplementary  Table  1.  Pathway  analysis  of  serum  metabolomics  data  comparing  all 
conditions.  Differentially  expressed  pathways when  all  conditions were  compared  (Lox  AL, 
AdicerKO AL, Lox DR and AdicerKO DR).  
 
Pathway Name Total Hits p FDR 
Fatty acid metabolism 39 1 0.012752 0.12663 
Valine, leucine and isoleucine biosynthesis 11 3 0.017801 0.12663 
Valine, leucine and isoleucine degradation 38 3 0.017801 0.12663 
Pantothenate and CoA biosynthesis 15 1 0.025044 0.12663 
Glycerophospholipid metabolism 30 2 0.026662 0.12663 
Phenylalanine, tyrosine and tryptophan biosynthesis 4 2 0.033377 0.12663 
Phenylalanine metabolism 11 2 0.033377 0.12663 
Aminoacyl-tRNA biosynthesis 69 17 0.04653 0.12663 
Selenoamino acid metabolism 15 1 0.047154 0.12663 
Taurine and hypotaurine metabolism 8 1 0.053879 0.12663 
Primary bile acid biosynthesis 46 1 0.053879 0.12663 
Tyrosine metabolism 44 1 0.056882 0.12663 
Ubiquinone and other terpenoid-quinone biosynthesis 3 1 0.056882 0.12663 
Arachidonic acid metabolism 36 1 0.058074 0.12663 
Linoleic acid metabolism 6 1 0.058074 0.12663 
alpha-Linolenic acid metabolism 9 1 0.058074 0.12663 
Histidine metabolism 15 4 0.059795 0.12663 
 
  



























































































































Arginine and proline metabolism 44 9 0.18956 0.37912 
Cysteine and methionine metabolism 27 2 0.21403 0.40408 
Glycine, serine and threonine metabolism 31 2 0.22678 0.40408 
Alanine, aspartate and glutamate metabolism 24 5 0.2624 0.40408 
Lysine biosynthesis 4 1 0.27126 0.40408 
Biotin metabolism 5 1 0.27126 0.40408 
Tryptophan metabolism 40 3 0.27569 0.40408 
Methane metabolism 9 1 0.30306 0.40408 
Cyanoamino acid metabolism 6 1 0.30306 0.40408 
Sphingolipid metabolism 21 1 0.30306 0.40408 
beta-Alanine metabolism 17 3 0.37459 0.47022 
Lysine degradation 23 2 0.37879 0.47022 
Glutathione metabolism 26 4 0.39554 0.47464 
Nitrogen metabolism 9 3 0.5897 0.68481 
Butanoate metabolism 22 1 0.63277 0.6903 
Porphyrin and chlorophyll metabolism 27 1 0.63277 0.6903 
D-Glutamine and D-glutamate metabolism 5 2 0.84868 0.89236 
Purine metabolism 68 1 0.89236 0.89236 
Pyrimidine metabolism 41 1 0.89236 0.89236 
 
  




























































































































































































































































Supplementary  Table  2.  Pathway  analysis  of  serum  metabolomics  data  in  AdicerKO  mice. 
Differentially expressed pathways when Lox ad libitum and AdicerKO ad libitum were compared.  
 
Pathway Name Total Hits p FDR 
Valine, leucine and isoleucine biosynthesis 11 3 2.20E-04 0.0039647 
Valine, leucine and isoleucine degradation 38 3 2.20E-04 0.0039647 
Phenylalanine, tyrosine and tryptophan biosynthesis 4 2 0.058927 0.44812 
Phenylalanine metabolism 11 2 0.058927 0.44812 
Selenoamino acid metabolism 15 1 0.078201 0.44812 
Aminoacyl-tRNA biosynthesis 69 17 0.0869 0.44812 
Tyrosine metabolism 44 1 0.099581 0.44812 
Ubiquinone and other terpenoid-quinone biosynthesis 3 1 0.099581 0.44812 
Pantothenate and CoA biosynthesis 15 1 0.11684 0.46735 
Alanine, aspartate and glutamate metabolism 24 5 0.21123 0.7081 
Tryptophan metabolism 40 3 0.21636 0.7081 
Cysteine and methionine metabolism 27 2 0.25371 0.73455 
Arachidonic acid metabolism 36 1 0.30606 0.73455 
Linoleic acid metabolism 6 1 0.30606 0.73455 
alpha-Linolenic acid metabolism 9 1 0.30606 0.73455 
Glycerophospholipid metabolism 30 2 0.37639 0.77163 
Histidine metabolism 15 4 0.38953 0.77163 
Nitrogen metabolism 9 3 0.41275 0.77163 
beta-Alanine metabolism 17 3 0.41291 0.77163 
Arginine and proline metabolism 44 9 0.48213 0.77163 
Lysine degradation 23 2 0.49067 0.77163 
Glutathione metabolism 26 4 0.50355 0.77163 
Purine metabolism 68 1 0.53907 0.77163 
Pyrimidine metabolism 41 1 0.53907 0.77163 
Butanoate metabolism 22 1 0.57659 0.77163 
Porphyrin and chlorophyll metabolism 27 1 0.57659 0.77163 
D-Glutamine and D-glutamate metabolism 5 2 0.57872 0.77163 
Methane metabolism 9 1 0.66013 0.79215 
Cyanoamino acid metabolism 6 1 0.66013 0.79215 
Sphingolipid metabolism 21 1 0.66013 0.79215 
Glycine, serine and threonine metabolism 31 2 0.69424 0.80621 
Fatty acid metabolism 39 1 0.76257 0.85789 
Taurine and hypotaurine metabolism 8 1 0.89892 0.92402 
Primary bile acid biosynthesis 46 1 0.89892 0.92402 
Lysine biosynthesis 4 1 0.92402 0.92402 
Biotin metabolism 5 1 0.92402 0.92402 
  




























































































































mice were subjected to ad  libitum  (AL) or dietary restriction  (DR) regimens  for one month. At the end of the protocol,
tissues were  isolated, minced and explants were used  to assess (A‐D)  complete oxidation of valine,  (E‐H) oxidation of
valine into α‐ketoisovaleric acid (αKIV), (I‐L) complete oxidation of palmitate, (M‐O) lipid synthesis from valine, and (P‐R)

































































































































mice were subjected  to ad  libitum  (AL) or dietary restriction  (DR) regimens  for up  to one month. Mice were euthanized at different
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Supplementary Figure 5. Adipocyte size and redox balance of WAT of AdicerKO mice. Twelve‐week old mice were subjected to
ad libitum (AL) or dietary restriction (DR) regimens for one month and WAT was isolated. (A,B) Tissue was processed for H&E staining and
(A) mean adipocyte size and (B) adipocyte type were blindly assessed using microscopic images (N=4‐5 animals per condition, one image
per animal collected always in the same anatomical location, i.e. around the inguinal lymph node). (C) Overall protein carbonylation was
assessed by immunoblot and quantitated (right panel) using image densitometry. (D) Reduced (GSH) and oxidized (GSSG) glutathione levels
were measured in tissue extracts (N=3‐5 animals per condition). Mean ± SEM. ‡ P < 0.05 for diet‐genotype interaction. 
Supplementary Figure 6. Glucose tolerance test and liver insulin signaling in AdicerKO mice.  Twelve‐week old mice
were subjected to ad libitum (AL) or dietary restriction (DR) regimens for three (A) or one (B) month. (A) Glucose tolerance test
was performed one week prior to the end of the protocol (N=5‐7 per condition). Mean ± SEM. ††† P < 0.001 Lox AL vs. Lox DR; ‡
P < 0.05, ‡‡‡ P < 0.001 AdicerKO AL vs. AdicerKO DR. (B) Western blots of liver extracts pAkt, phospho‐Akt. pErk1/2, phospho‐
Erk1/2. Numbers are quantitation of blots (fold expression in comparison to control group) ± SEM. * P < 0.05, ** P < 0.01 for
genotype effect; †† P < 0.01, ††† P < 0.001 for diet effect; ‡ P < 0.05, ‡‡ P < 0.01 for diet‐genotype interaction.    
